|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Interest income and other expense, net | |||||
| Gain from sale of property and equipment | |||||
| Change in fair value of warrant liability | |||||
| Sublease income | |||||
| Related party | |||||
| Total sublease income | |||||
| Loss before equity method investment | |||||
| Loss from equity method investment | |||||
| Net loss | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Shares used to compute net loss per share, basic | |||||
| Shares used to compute net loss per share, diluted | |||||
| Other comprehensive loss: | |||||
| Unrealized gain (loss) on marketable securities | |||||
| Cumulative foreign currency translation adjustment | |||||
| Comprehensive loss |
Loading...
